Terrill Dicki
Sep 30, 2026 11:46 UTC
NVIDIA trades at $228.52 with a historic $235 billion buyback authorization and 55 analysts screaming “Buy” — yet price is pinned just below a critical $231.88 resistance. Either the AI cash machin…
Jensen Huang Just Dropped the Largest Buyback in Corporate History — Here’s Why the Price Isn’t Exploding (Yet)
Two days ago, NVIDIA’s board authorized an additional $150 billion in share repurchases, lifting its total remaining buyback program to a jaw-dropping $235 billion — the largest such authorization in U.S. corporate history, surpassing Apple’s famous $110 billion announcement. CEO Jensen Huang framed it plainly: “NVIDIA’s growth is being driven by a once-in-a-generation platform shift to AI and accelerated computing. Our cash generation gives us the capacity to invest in the technologies that advance this transformation and return capital to shareholders.”
That’s not a press release. That’s a confidence statement backed by $99.4 billion in cash, $33.4 billion in debt, and $69 billion in free cash flow generated through just the first six months of the current fiscal year. This is a company printing money at a pace that makes the buyback math feel almost conservative. And yet, as of 09:57 UTC this morning, NVDA sits at $228.52 — down 1.02% on the session, barely off its 24-hour low of $227.31, and still roughly 3% below its 52-week high of $236.54.
The market is not ignoring the buyback. It’s digesting it. There’s a difference. As reported and tracked on Blockchain.news, institutional activity in AI-exposed equities has remained the dominant driver of large-cap tech price action in 2026, and NVIDIA is the apex expression of that theme.
The Chart Is Building Compression — Support Held, But the Lid Is On
From a pure price structure standpoint, NVIDIA is doing exactly what you’d expect from a stock sitting in late-stage consolidation after a multi-month run. All three moving averages — the SMA 7 at $226.52, the SMA 20 at $222.33, and the SMA 50 at $222.22 — are stacked bullishly beneath the current price. That alignment tells you the trend is intact and the floor is rising.
But momentum has flatlined. The MACD and its signal line have converged to near-identical readings, producing a histogram of essentially zero — buyers and sellers are in a dead stalemate at current levels. The RSI at 59 is constructive but not explosive; it’s sitting in the neutral-to-bullish zone without the kind of conviction you see when a stock is about to break out.
The Bollinger Band picture adds texture. Price is sitting at the 79th percentile of the current band range — upper band at $232.93 — which means there’s limited room to push higher without either expanding volatility or pulling back. The immediate resistance at $231.88 is the first real test, and the stronger ceiling at $235.23 aligns almost precisely with the 52-week high at $236.54. That’s a dense overhead zone. A clean break above $235 on volume changes the entire near-term narrative. Below $226.24 — the immediate support — and you’re looking at a re-test of the $222–$224 range where the SMA 20 and SMA 50 are clustered.
Derivatives positioning supports the mild bull bias. The funding rate is positive at 0.0137%, institutional long/short positioning shows 56.1% long among top traders, and taker buy/sell flow is tilted modestly toward buyers at 1.09. Open interest has barely moved — down 0.68% in 24 hours. This is not a market panicking. It’s a market waiting for a reason to commit.
The Fundamental Case Is Extraordinary — And Wall Street Knows It
Let’s be direct: NVIDIA’s fundamentals are among the best in the history of large-cap technology stocks. Q2 FY2027, reported August 26, showed revenue surge 105.9% year-over-year to $96.22 billion, crushing the consensus estimate of $92.27 billion. EPS of $2.22 beat estimates by $0.13. Management guided Q3 FY2027 revenue to $108 billion, plus or minus 2% — and Wall Street’s consensus is already above the top of that range at $111.3 billion, because this company has beaten guidance consistently for six consecutive quarters.
The valuation story is the one that should be jumping off the page for any serious investor. Trailing P/E sits at approximately 27–28x, against a three-year average closer to 42x. Net margins are running at 63.7% on a trailing twelve-month basis — the highest in a decade. Revenue on a TTM basis is $303 billion. The Trefis analysis pegs NVDA as worth roughly 55% more in three years even under conservative assumptions of slowing growth and P/E compression. At a PEG ratio of just 0.45, this stock is arguably cheap relative to its growth trajectory.
The analyst community is aligned with near-unanimity that this is the buy of a generation. Based on data tracked via Blockchain.news and confirmed by Yahoo Finance consensus metrics, 59 analysts have NVIDIA rated, with 58 recommending a buy and just 1 as a sell. The mean 12-month price target is $327.70, the median sits at $315, and the high-end target reaches $515. Even the low-end target of $180 from the most cautious analyst represents a view that has been comprehensively demolished by earnings reality. Goldman Sachs is at $300 with a Buy, BMO Capital at $340, Cantor Fitzgerald at $350, Bernstein at $400, Bank of America at $350, and J.P. Morgan at $320. The floor of serious Wall Street conviction is well above where the stock is trading today.
The next earnings report is estimated for mid-to-late November 2026, and based on Q3 FY2027 guidance of ~$108 billion in revenue — up from $57 billion a year ago — NVDA is on track to deliver its fourth consecutive quarter of accelerating year-over-year growth. The Vera Rubin platform, which began shipping in August, is expected to represent roughly 20% of data center revenue in Q3 — and management is crystal clear: the constraint is supply, not demand, at least through fiscal year 2028.
Price Scenarios for the Next 7–30 Days: Pick Your Entry, Know Your Stop
The base case — probability roughly 60% — is a controlled grind higher over the next two to three weeks, with NVDA consolidating in the $225–$232 range before the $235.23 resistance zone is tested in earnest. The $235 billion buyback authorization provides a structural bid that prevents meaningful downside from materializing on anything short of a macro shock. Intermediate-term target in this scenario: $250–$260, achievable before the November earnings catalyst.
The bull case — probability around 25% — kicks in if a single daily close above $235.23 on volume above the three-month average of 128 million shares triggers a momentum squeeze. Institutional investors who have been slow-walking their way into the position re-accelerate, short sellers (short interest is only 1.29% of float, so this isn’t a squeeze story per se) re-evaluate, and the stock runs toward the $270–$280 zone. Bernstein’s $400 target and the $327.70 consensus mean start to feel like speed bumps rather than ceilings.
The bear case — probability around 15% — requires a macro deterioration: a Fed statement that resets rate-cut expectations, a broader Nasdaq selloff, or a Q3 revenue miss versus the elevated $111 billion consensus. In that scenario, NVDA revisits $222–$224 where the SMA 20 and SMA 50 are layered and the prior breakout base was established. That zone should be treated as a strong buy-the-dip level for longer-term holders.
For tactical traders: entries in the $226–$229 range are clean, with a stop below $223.50. The 7-day target is a test of $231.88 resistance; the 30-day target, barring macro disruption, is $250+. The $228.52 current price is not a heroic entry, but it’s not a bad one either given that every moving average of consequence is well below it. NVDA has generated a 974% five-year return for a reason — it’s not a coincidence, it’s a compounding machine with a $235 billion buyback backstop and the most lopsided analyst consensus of any mega-cap stock on the planet.
Fundamental data, analyst ratings and price targets are sourced from Yahoo Finance as of September 30, 2026 and reflect consensus estimates, not investment advice.
Image source: Shutterstock
Be the first to comment